Brazikumab (Anti-IL-23)

Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn's disease. MW: 144.82 KD.

• Supplier: Selleck Chemicals
• Product #: A2965
• Sku #: A2965-1mg*5